Armed T cells with CAR for cancer immunotherapy

被引：0
作者：
Wei, Yu-Quan [1 ]
机构：
[1] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Collaborat Innovat Ctr Biotherapy, Chengdu 610041, Peoples R China
来源：
SCIENCE CHINA-LIFE SCIENCES | 2016年 / 59卷 / 04期
关键词：
EXPRESSION; CD19;
D O I：
10.1007/s11427-016-5047-0
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：331 / 332
页数：2
相关论文
共 50 条
  • [21] Targeting the epigenome to reinvigorate T cells for cancer immunotherapy
    Xiong, Dian
    Zhang, Lu
    Sun, Zhi-Jun
    MILITARY MEDICAL RESEARCH, 2023, 10 (01)
  • [22] Genome Editing in Engineered T Cells for Cancer Immunotherapy
    Bonini, Chiara
    Chapuis, Aude G.
    Hudecek, Michael
    Guedan, Sonia
    Magnani, Chiara
    Qasim, Waseem
    HUMAN GENE THERAPY, 2023, 34 (17-18) : 853 - 869
  • [23] Precision Immunotherapy Utilizing Adapter CAR-T Cells (AdCAR-T) in Metastatic Breast Cancer Leads to Target Specific Lysis
    Oender, Cansu E.
    Moustafa-Oglou, Moustafa
    Schroeder, Sarah M.
    Hartkopf, Andreas D.
    Koch, Andre
    Seitz, Christian M.
    CANCERS, 2024, 16 (01)
  • [24] Engineered T-cell Receptor T Cells for Cancer Immunotherapy
    Greenbaum, Uri
    Dumbrava, Ecaterina, I
    Biter, Amadeo B.
    Haymaker, Cara L.
    Hong, David S.
    CANCER IMMUNOLOGY RESEARCH, 2021, 9 (11) : 1252 - 1261
  • [25] CAR T Cells
    Tudor, Thilan
    Binder, Zev A.
    O'Rourke, Donald M.
    NEUROSURGERY CLINICS OF NORTH AMERICA, 2021, 32 (02) : 249 - 263
  • [26] An introduction to chimeric antigen receptor (CAR) T-cell immunotherapy for human cancer
    Feins, Steven
    Kong, Weimin
    Williams, Erik F.
    Milone, Michael C.
    Fraietta, Joseph A.
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 : S3 - S9
  • [27] Ephrin A1 ligand-based CAR-T cells for immunotherapy of EphA2-positive cancer
    Liu, Nan
    Wei, Wenwen
    Ren, Kexing
    Liang, Dandan
    Yang, Dong
    Zhang, Weishan
    Yang, Beibei
    Sun, Bin
    Zhao, Jincheng
    Cao, Dan
    Zou, Liqun
    Zhao, Xudong
    MEDCOMM-ONCOLOGY, 2025, 4 (01):
  • [28] CAR T Cell Immunotherapy Beyond Haematological Malignancy
    Hupperetz, Cedric
    Lah, Sangjoon
    Kim, Hyojin
    Kim, Chan Hyuk
    IMMUNE NETWORK, 2022, 22 (01)
  • [29] Developing a safe and effective CAR T-cell immunotherapy for breast cancer: progress and pitfalls
    Antoine, Pierre
    Maher, John
    BREAST CANCER MANAGEMENT, 2020, 9 (03)
  • [30] Regulation of PD-1 in T cells for cancer immunotherapy
    Yu, Xibao
    Gao, Rili
    Li, Yangqiu
    Zeng, Chengwu
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 881
12345